Gossamer Bio, Inc. (GOSS)
Gossamer Bio Market Cap: 722.14M for Dec. 30, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| XOMA Royalty Corp. | 325.06M |
| Rezolute, Inc. | 202.61M |
| NovaBay Pharmaceuticals, Inc. | 772.45M |
| Palatin Technologies, Inc. | 13.39M |
| Theriva Biologics, Inc. | 6.397M |
Market Cap Related Metrics
| PS Ratio | 16.09 |
| PEG Ratio | -0.0417 |
| Price | 3.12 |
| Earnings Yield | -22.03% |
| PEGY Ratio | -0.0417 |